Integrated early palliative care for patients with newly diagnosed glioblastoma: The GLIOSUPPORT feasibility study.

ABSTRACT:

Background

Early palliative care improves the quality of life (QoL) and survival in patients with cancer; however, its effects in patients with glioblastoma remain unclear. The GLIOSUPPORT study assessed the feasibility (adherence; primary objective) of an early palliative care program integrated into the standard glioblastoma care pathway. Secondary objectives included the description of the patients' characteristics, QoL, and neuropsychological changes over time, end-of-life decisions, end-of-life treatments, and family carers' perceptions/experiences.

Methods

This interventional, prospective, longitudinal, feasibility study was conducted in a French comprehensive cancer center. Thirty-five patients with newly diagnosed glioblastoma were required to reach an adherence rate

SUBMITTER: Fabbro M 

PROVIDER: S-EPMC12063082 | biostudies-literature | 2025 Jan-Dec

REPOSITORIES: biostudies-literature